PATENT CLAIM ANALYSIS

Application Number: 15997040
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["548", "364100"]

Abstract:
The present disclosure relates to solid crystalline forms of N—((S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)-propan-2-yl)-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide (I) and the diastereomers thereof, and to methods for preparing such crystalline forms. Compound (I) and the diastereomers thereof are potent androgen receptor (AR) modulators useful as a medicament.

Claim (Index 5):
Crystalline form I\u2033 of N\u2014((S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-5((R)-1-hydroxyethyl)-1H-pyrazole-3-carboxamide (Ib) having an X-ray powder diffraction pattern comprising characteristic peaks at about 9.2, 10.9, 15.1, 15.8, and 22.1 degrees 2-theta, wherein the crystalline form I\u2033 is substantially free of any other crystalline form of N\u2014((S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propan-2-yl)-5-((R)-1-hydroxyethyl)-1H-pyrazole-3-carboxamide (Ib).

Metadata:
- Claim Count in Document: 27.0
- Percentile: 94.0
- Lexical Diversity: 1.55814
- Patent Class: 548.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15547193', '15997028', '15564878', '14110596', '12561398']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7224050652041919
- 35 USC 102 Novelty (BERT): 0.6142282175650878
- Combined Prediction Score: 0.7115873804402816
- Mean Citation Score: 405.072322
- Max Citation Score: 537.6759999999998
- Similarity Product: 515.0493199894427

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test